Macquarie University is a public research university based in Sydney, Australia, in the suburb of Macquarie Park. Founded in 1964 by the New South Wales Government, it was the third university to be established in the metropolitan area of Sydney.

During the past decade, Macquarie University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Macquarie University" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "Institut Curie" with 1 trials as a collaborator and "International Drug Development Institute" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Macquarie University" are "ER-Negative Breast Cancer" (1 trials), "HER2-positive Breast Cancer" (1 trials), "Node-negative Breast Cancer" (1 trials), "PR-Negative Breast Cancer" (1 trials) and "Urothelial Cancer" (1 trials). Many other conditions were trialed in "Macquarie University" in a lesser frequency.

Most popular intervention types in "Macquarie University" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (1 trials), "Erdafitinib" (1 trials), "Fibroblast Growth Factor Receptor inhibitor Clinical Trial Assay (FGFRi CTA)" (1 trials), "Pembrolizumab" (1 trials) and "Pertuzumab and tratuzumab fixed dose combination" (1 trials). Other intervention names were less common.

The vast majority of trials in "Macquarie University" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Macquarie University". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Macquarie University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Macquarie University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".